Skip To Main Content
Maya Sakakibara on Muck Rack

Maya Sakakibara

As seen in: Wiley Online Library, MDPI
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Maya

Contact Maya, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Immune‐related adverse event detection in liver cancer patients treated with immune checkpoint inhibitors: Nationwide exploratory survey in Japan

|
By Masako Shomura, Haruka Okabe, Maya Sakakibara, Naho Yaguchi
| Wiley Online Library Verified
AE adverse event HCC hepatocellular carcinoma ICI immune checkpoint inhibitor irAE immune-related adverse event INTRODUCTION Hepatocellular carcinoma, which accounts for more than 90% of primary liver cancers, is a refractory cancer with a high recurrence rate despite the presence of curative treatments, such as surgical resection and ablation1, 2; thus, the number of molecular targeted therapies used to treat advanced HCC has increased to seven.
Open in Who Shared Issue with article?

Impact of Atezolizumab + Bevacizumab Therapy on Health-Related Quality of Life in Patients with Advanced Hepatocellular Carcinoma

|
By Haruka Okabe, Emi Sato, Masako Shomura, Maya Sakakibara
| MDPI
All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.
Open in Who Shared Issue with article?
See all 2 articles